Viemed Healthcare (NASDAQ:VMD) Director Timothy Smokoff Sells 20,000 Shares

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Timothy Smokoff sold 20,000 shares of the business’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the completion of the transaction, the director owned 75,518 shares in the company, valued at $868,457. The trade was a 20.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Viemed Healthcare Price Performance

VMD traded down $0.06 on Friday, hitting $11.63. 882,599 shares of the company’s stock traded hands, compared to its average volume of 260,443. The company has a current ratio of 1.22, a quick ratio of 1.10 and a debt-to-equity ratio of 0.06. Viemed Healthcare, Inc. has a one year low of $5.93 and a one year high of $11.88. The company’s 50 day simple moving average is $9.87 and its 200-day simple moving average is $8.82. The firm has a market cap of $445.89 million, a price-to-earnings ratio of 31.43 and a beta of 1.12.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.03). The company had revenue of $75.41 million for the quarter, compared to the consensus estimate of $74.40 million. Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. As a group, research analysts anticipate that Viemed Healthcare, Inc. will post 0.44 EPS for the current year.

Institutional Investors Weigh In On Viemed Healthcare

Several large investors have recently added to or reduced their stakes in the stock. AQR Capital Management LLC bought a new position in shares of Viemed Healthcare during the 1st quarter valued at approximately $90,000. Jane Street Group LLC bought a new stake in Viemed Healthcare during the 1st quarter valued at $394,000. Geode Capital Management LLC raised its holdings in shares of Viemed Healthcare by 2.0% in the second quarter. Geode Capital Management LLC now owns 798,515 shares of the company’s stock valued at $5,519,000 after acquiring an additional 15,353 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Viemed Healthcare by 3.0% in the 2nd quarter. JPMorgan Chase & Co. now owns 174,551 shares of the company’s stock worth $1,206,000 after purchasing an additional 5,099 shares during the period. Finally, Rhumbline Advisers lifted its holdings in Viemed Healthcare by 9.0% during the second quarter. Rhumbline Advisers now owns 51,456 shares of the company’s stock worth $356,000 after buying an additional 4,228 shares during the period. 74.24% of the stock is owned by institutional investors.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.